Solid forms comprising an ampa positive allosteric modulator

TW202641522APending Publication Date: 2026-10-16NEUROCRINE BIOSCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114149914
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-12-11
Filing Date
2025-12-18
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080731_001
    Figure TWG2TA001080731_001
  • Figure TWG2TA001080731_002
    Figure TWG2TA001080731_002
  • Figure TWG2TA001080731_003
    Figure TWG2TA001080731_003
Patent Text Reader

Abstract

This invention relates to a solid form of 9-(4-(cyclohexyloxy)phenyl)-7-methyl-3,4-dihydropyro[2,1-c][1,2,4]thiadi-2,2-dioxide (compound (I)), compositions comprising the same, and methods of preparation and use thereof, for example for the prevention or treatment of central nervous system diseases. Solid forms comprising 9-(4-(cyclohexyloxy)phenyl)-7-methyl-3,4-dihydropyrazino[2,1-c][1,2,4]thiadiazine 2,2-dioxide (Compound (I)), compositions comprising the same, and methods of making and using the same, for example, in the prevention or treatment of a central nervous system disease.
Need to check novelty before this filing date? Find Prior Art